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Abstract 
With the introduction and discharge of thousands of new micropollutants (MPs) every year, traditional water and 
wastewater treatment plants may be incapable of tackling them all. With their low concentrations and diver- sity in 
nature, MP removal encounters numerous challenges. Although some MPs are effectively eliminated via conventional 
treatment methods, most of them can easily escape and are retained in the discharged effluent. Therefore, advanced 
methods such as (i) adsorption, (ii) oxidation and advanced oxidation processes (O3 and O3-based advanced oxidation 
processes, UV/H2O2), (iii) membrane processes, and (iv) membrane bioreactors, become an inevitable approach. 
Despite the unsurprisingly vast number of papers on MP treatment available at present, most of these studies were 
carried out at a laboratory scale while only a few pilot- and full-scale stud- ies have experimented. Nevertheless, an in-
depth assessment of real-world MP treatment methods is extremely crucial for practitioners. To date, no paper has 
been dedicated to look at this issue. Therefore, this paper aims to review these large-scale treatment methods. First, the 
paper goes through the regulations and standards which deal with MPs in water courses. It will then assess these 
methods in various case-studies with reference to differ- ent criteria towards serving as a reference for further practical 
applications. 
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To date, conventional water and wastewater treatment plants have 
successfully controlled basic pollutants such as organic matters, nutri- 
ents and pathogens. However, with the introduction and, consequently, 
discharge of thousands of new anthropogenic substances every year, 
traditional plants may fail to tackle them. A majority of these substances 
are called micropollutants (MPs) because they are present in the water 
environment in small amounts but can be highly toxic, even at extreme- 
ly low concentrations (below several μg/L) (Luo et al., 2014). Basically 
MPs can be classified into four major groups, although there may be 
some overlaps between different groups, namely (i) metals, metalloids 
and radioactive elements (i.e., antimony, arsenic, cadmium, lead, mer- 
cury, radon, uranium); (ii) organic MPs (i.e., hydrocarbons, solvents, 
surfactants, personal care products, pesticides); (iii) hormones; and 
(iv) pharmaceutical products and endocrine disruptors (i.e., analgesics, 
antibiotics, antidepressants, betablockers, hypolipidemic, bronchodila- 
tors, and chemotherapy products) (Degremont, 2013). 
These substances have not been encountered in any design process 
of traditional water and wastewater treatment plants. As Blackbeard 
et al. (2016) observed, there were 91 MP compounds consistently pre- 
sented in the secondary-treated effluent from Eastern Treatment Plant 
(Australia). In another survey carried out by Thomaidi et al. (2015) in 
Greece, about 207 organic MPs were detected in different WWTPs, 
ranging from 1 ng/L to thousands ng/L. Components with highest con- 
centrations for specific groups were acesulfame (27,200 ng/L, in artificial 
    
sweeteners group), nonylphenol diethoxylate (NPE) (17,400 ng/L, in en- 
docrine disrupting compounds (EDCs) group), valproic acid (17,292 ng/ 
L in pharmaceuticals group), decamethylcyclopentasilane (6020 ng/L, in 
siloxanes group), tolytriazole (5773 ng/L, in benzotriazoles group), and 
perfluoroundecanoic acid (1281 ng/L, in perfluorinated compounds 
group) (Thomaidi et al., 2015). The Swiss National Research Program 
50 investigated over a wide range of MP discharge sources and conclud- 
ed that WWTPs were the key route for introduction of MPs and EDCs 
into the aquatic environment (Eggen et al., 2014). 
Although effects of all MPs on the environment and human health 
are not fully understood, abundant scientific evidence has confirmed 
that some pharmaceuticals and EDCs (nonylphenol, NPE, nonylphenol 
monoethoxylate and triclosan) were a hazard to aquatic organisms 
(Logar et al., 2014; Jones et al., 2007) where they contributed to 99% 
of toxicity to fish and Daphnia magna, and 98% to algae (Thomaidi et 
al., 2015). Even with the high dilution factor of rivers (N 2000 times), 
MPs remained a risk for aquatic ecology with risk quotient values of 
40–120 for algae, daphnia and fish (Thomaidi et al., 2015). 
With MPs' low concentrations and diversity in nature, there are nu- 
merous challenges involved in their removal. Although some MPs are 
partly removed via conventional treatment  methods  through 
vaporisation or sorption onto activated sludge such as fragrances 
(40%), nonylphenol monoethoxylate (13%) and Bisphenol A (40%) 
(Luo et al., 2014), most of them can easily escape from bioreactors and 
are retained in discharged effluents (X. Li et al., 2015). Therefore, ad- 
vanced methods become an inevitable approach. Indeed, tertiary 
 
 
methods such as (i) adsorption, (ii) oxidation and advanced oxidation 
processes (O3, O3-based advanced oxidation processes, UV/H2O2), (iii) 
membrane processes, (iv) membrane bioreactors and their hybrid pro- 
cesses were studied extensively to remove MPs in the past decades. 
Despite the number of papers on MPs treatment is unsurprisingly 
tremendous, most of them were experimented at a laboratory scale 
while only a few pilot- and full-scale studies have carried out. Neverthe- 
less, an in-depth assessment of real-world MP treatments is extremely 
crucial for practitioners. As lab-scale experimental conditions are signif- 
icantly different with actual water/wastewater matrix and operational 
conditions, a successful laboratory treatment process does not guaran- 
tee its success on a larger scale. Pilot-scale studies are, thus, required 
to simulate real treatment processes prior to full-scale execution. A 
proper pilot-scale plant with a whole set of “real” operational parame- 
ters can provide an accurate portrait of a full-scale plant, albeit some 
cautions of the scaling must be taken into account. Pilot-scale is often 
sufficient enough to extend our knowledge towards MP treatment of a 
particular treatment train. Nonetheless, learning from full-scale case 
studies is still the best option as it involves various aspects of a treat- 
ment process rather than efficiency alone. 
To date, no paper has been dedicated to look at this issue. Therefore, 
this paper aims to review the treatment methods in pilot- and full-scale. 
First, it goes through the MP regulations in different countries and visits 
a case study of Swiss national strategy in their efforts to control MPs. It 
will then assess these large-scale methods in various case-studies with 
reference to different criteria towards serving as a reference for further 
practical applications. 
 




The fundamental question of how many or to what extent MPs 
should be regulated is very troublesome for any decision maker. This 
is because MP compounds are diverse in nature, even within the same 
family. To regulate a substance, an extensive research program must 
be done to provide a scientific background, including identification its 
source, fate, transformation and toxicity in different environments. To 
date, nearly 600 compounds have been defined but only a small number 
of them are regulated (Table 2). The fate of thousands of other MPs are 
unclear. 
The Water Framework Directive WFD (2000/60/EC) was recognised 
as the first regional effort to address 33 priority substances. This direc- 
tive has subsequently been refined by the Decision No. 2455/2001/EC 
and the Environmental Quality Standards Directive (2008/105/EC). In 
2013, 12 more substances were added to the list, making up to 45 reg- 
ulated compounds. However, there are many more problematic com- 
pounds present, apart from those compounds (Metz and Ingold, 2014). 
At national level, Switzerland is the first country in the world impos- 
ing MP control at the point source. The proposal of Federal Office for the 
Environment to reduce MP loadings by 80% at selected WWTP outlets 
was approved by the Swiss parliament in 2011. Subsequently, the MP 
control in WWTP effluents was regulated in the Ordinance on Water 
Protection after a series of public consultation from 2012 to 2014, 
which will be in effect in 2016 (Audenaert et al., 2014). In the cases 
USA, there is no official control in MP elimination, except few states, 
i.e. California, issued their own regulations separately (Audenaert et 
al., 2014). 
Whereas the release of some groups (i.e., pesticides and metals) de- 
clines due to stricter source reduction strategies, pharmaceutical dis- 
charge tends to  increase over time (Metz  and Ingold, 2014). The 
concerns over potential risks of some substances (especially antibiotics 
and EDCs) on water organisms and public health are ongoing. Nonethe- 
less, it is unlikely that pharmaceutical compounds are regulated soon, 
although there was a proposal to add 17α-ethinylestradiol, 17β-estradiol 
and diclofenac to the WFD list in 2011 (Johnson and Sumpter, 2015). 
This is due to (i) their benefits and widespread uses for human health, 
(ii) inadequacy of scientific evidence on the impacts of these com- 
pounds in water courses, and (iii) lacking of systematic monitoring of 
various pharmaceuticals (NRMMC, 2015). One exceptional endeavour 
was the Australian government's effort in establishing threshold values 
for MPs, including pharmaceuticals, in secondary effluents for reuse in 
water supply areas in Australian Guidelines for Water Recycling: Augmen- 
tation of Drinking Water Supplies (NRMMC, 2008). In short, the compar- 
ison of control regulations in EU, USA, Australia and Switzerland was 
briefly presented in Table 1. The preferred technologies were statistical- 
ly summarised, rather than officially defined in any legal documents. 
Table 2 presents several legislative requirements of MPs control in 
the water sector. The paper will focus on organic MPs, pharmaceuticals 
and steroid hormones – either regulated or non-regulated. This table 
presented different regulations for various types of MPs in a wide 
range of water environment. It can be seen that the concerns relating 
to MPs were bound strongly with drinking water rather than effluent 
discharge. To date, only Australian guidelines for water recycling: aug- 
mentation of drinking water supplies (NRMMC, 2008) and Report on 
public health criteria for direct potable reuse systems (Audenaert et 
al., 2014) have mentioned about standards for effluent discharge. It is 
noteworthy to mention that in Table 2, some MPs may fall into different 
classifications, depending on their nature and use. 
 
2.2. Case study – Swiss Government's National Research Program 50 
 
2.2.1. Ideology 
Switzerland is the pioneer country to enforce legal obligations for 
minimization of MP loadings from municipal WWTPs. Four criteria 
were set up to screen whether a WWTP should be upgraded to control 
MPs discharge, based on the following principles (Eggen et al., 2014): 
 
• Serving capacity of WWTP (N 80.000 persons); 
• Sensitivity of receiving waters (drinking water reservoirs or sensitive 
areas); 
• Dilution capacity of receiving waters (N 10% of the dry-season stream 
flow);  
 
Accordingly, 123 out of 750 WWTPs need to be improved, with the 
estimated costs of CHF 133 million (equivalent to 135 million USD) 
per year for the program lifespan of 24 years, from 2016 to 2040 
(Logar et al., 2014). By imposing 80% MP elimination target for the 
screened WWTPs, the national MP loading is expected to reduce by 
50% (Mulder et al., 2015). 
With reference to the “polluter-pays principle”, the financial contri- 
bution to the project is divided as following – 75% from the central gov- 
ernment and 25% from the municipalities (Audenaert et al., 2014). 
Indicator compounds selected for monitoring the treatment processes 
are benzotriazole, carbamazepine, diclofenac, sulfamethoxazole and 
mecoprop. These MPs were selected because they often (i) appear in 
wastewater and surface waters, (ii) have a low removal rate in conven- 
tional WWTPs, (iii) represent a wide range of components in wastewa- 
ter (pesticides, pharmaceuticals and industrial compounds) and (iv) 
can be detected easily by high-performance liquid chromatography 
(Eggen et al., 2014; Mulder et al., 2015). 
 
2.2.2. Early critics 
However, the Swiss proactive initiative was initially criticised being 
a premature decision for (i) not considering all ecological aspects, (ii) 
exposing a financial burden to the society, and (iii) providing ambigu- 
ous environmental benefits (Johnson and Sumpter, 2015; Jones et al., 
2007). In contrast, Stamm et al. (2015) countered these critiques, con- 
sidering that the decision was made with adequate scientific, economic 
and social data. From a technical viewpoint, several pilot- and full-scale 
projects have been tested for MP removal efficiencies, energy demands 
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and additional budget for upgrading and operation (Hollender et al., 
2009). Full-scale upgraded plant's operational cost increases from 5% 
to 35%, depending on the nature of current treatment technologies 
and upgrading options (Logar et al., 2014). In addition, the widespread 
and consistent upgrading of WWTPs definitely reduces the toxicity 
from MPs in the environment, and positively contributes to natural res- 
toration and water reservoirs. Actually, a societal decision-making al- 
ways involves a certain degree of uncertainty. Therefore, uncertainty 
is not an excuse for “non-action” scenario. The movement in Switzer- 
land is also an opportunity to observe the responses of natural ecosys- 
tems from large-scale implementation of mitigation measures (Stamm 
et al., 2015). 
  
2.2.3. Lessons learnt 
Several lessons can be drawn from the case study of Swiss WWTP 
upgrading program for MP control. Firstly, a successful control of MPs 
must come from the government level with clearly defined goals 
The pilot- and full-scale case studies used in this paper are 
summarised in Table 3. Seven full-scale plants, either drinking water 
or wastewater treatment, and 14 pilot-scale cases within a decade 
have been assessed towards five above-mentioned criteria. The results 
from these cases will be discussed in the following sections. 
 
3.2.  Range of  treated pollutants, treatment  efficiency and  removal 
mechanisms 
 
It is noteworthy that concentrations of MPs vary greatly from one 
source to another. Pharmaceuticals, personal care products, EDSs and 
surfactants from raw municipal wastewater are often found in the 
range of 10− 4–104 μg/L (Luo et al., 2014). Meanwhile, MPs in surface 
water could be pesticides, PPCPs, EDSs, surfactants and industrial sub- 
stances resulting from agricultural run-off, municipal and industrial 
wastewater discharges. Surprisingly, some MPs presented in surface 
water with a higher concentration than in municipal wastewater, for 
which are translated to legal obligations and practical implementation 
measures. However, it is not the only factor. The success to integrate 
example tetracycline (10− 4 
2014). 
–103 μg/L in surface water) (Cazes et al., 
MP control regulation into law was a result of a harmonious combina- 
tion of top-down and bottom-up approaches. This decision-making pro- 
cess involved all relevant stakeholders from public, scientists and 
practitioners to politicians. They were consulted in a democratic man- 
ner over a long period of time with a variety of venues and methods. 
The key to its triumph was to raise public awareness on the effects of 
MPs and the MP control initiative. As a result, even this large-scale im- 
plementation has not proved its environmental effects yet (which 
often requires long-term evidences), it already brings higher percep- 
tions in the public and politicians towards environmental issues. In ad- 
dition, this case study provided a solid background for answering the 
question whether a WWTP should be upgraded and which MPs should 
be used as proxy. Although different countries may have different set of 
conditions, these basic properties such as (i) capacity of WWTPs and (ii) 
sensitivity and dilution factors of receiving waters must be taken into 
account. 
  
3. Multicriteria assessment of advanced treatment technologies 
 
3.1. Theoretical framework and case studies for assessment 
 
Eggen et al. (2014) proposed several criteria to assess MP removal 
methods, such as (i) having a sound scientific and technical basis, (ii) 
based on broad societal and political acceptance, (iii) technically feasi- 
ble, (iv) manageable, (v) pragmatic, (vi) adaptable in time and (vii) fi- 
nancially feasible. These criteria have been reorganised to evaluate MP 
advanced treatment alternatives, including (i) range of treated pollut- 
ants, treatment efficiency and removal mechanisms, (ii) environmental 
friendliness, (iii) simplicity of operation and maintenance, (iv) cost-ef- 
fectiveness and (v) social acceptance. 
The removal of these contaminants is mainly based on their distinc- 
tive physio-chemical behaviours in certain conditions, including (i) hy- 
drophobicity, (ii) absorbability, (iii) volatility, (iv) biodegradability, (v) 
charge, and (vi) molecular weight and size. As a rule of thumb, a group 
of substances with a similar characteristic will behave consistently to- 
wards a single treatment method. Table 4 simplifies the selection of 
suitable methods towards specific groups of substances on the ground 
of their physiochemical characteristics. Of course, due to the diversity 
of substance properties, prediction solely based on these characteristics 
may lead to conflicting results. Therefore, this table is not a comprehen- 
sive guideline, rather it aims to provide a better understanding on be- 
haviour of compounds with comparable properties. 
In the matrix of treatment process and physiochemical properties, 
MPs are classified as highly, moderately or insignificantly removed 
(Table 4). Obviously, one method cannot remove all contaminants. In 
some instances, an MP cannot be treated in one treatment can be re- 
moved by another method. For example, carbamazepine is hardly elim- 
inated in any treatment other than advanced oxidation. The most 
challenging groups of MPs are those having (1) high water solubility, 
(2) low sorption coefficients, (3) low biodegradability and (4) high 
chemical stability (Zwiener, 2006). 
 
3.2.1. Activated carbon adsorption 
Activated carbon adsorption is a common method to remove odour, 
taste and organic compounds in water treatment plants, and currently 
being extended to remove MPs in WWTPs. Whereas granular activated 
carbon (GAC) is often utilised as a filtration medium, powdered activat- 
ed carbon (PAC) is added in activated sludge or coagulation tanks (Luo 
et al., 2014). The adsorption processes are controlled by contact time 
(PAC) and empty bed contact time EBCT (GAC). This method is suitable 




Summary of common regulated and non-regulated MPs in water sector. 
 
No.   Substance groups Legislative 
body 
 
Regulations Domain Substances1 (μg/L) References 
 
1. Organic MPs 
a. Pesticides and 
herbicides 
 
Europe EU Directive 98/83/EC Drinking water Individual pesticide ≤ 0.1 












USEPA National Primary Drinking 
Water Regulations 
Drinking water Alachlor (20); Aldicarb (10); Aldrin & dieldrin (0.03); 
Atrazine (100); Carbofuran (7); Chlordane (0.2); 
Chlorotoluron (30); Chlorpyrifos (30); Cyanazine (0.6); 2,4-D 
(30); 2,4-dB (90); 1,2-Dibromo-3-chloropropane (1); 
1,2-Dibromoethane (0.4); 1,2-Dichloropropane (40); 
1,3-Dichloropropene (20); Dichlorprop (100); Dimethoate 
(6); Endrin (0.6); Fenoprop (9); Hydroxyatrazine (200); 
Isoproturon (9); Lindane (2); MCPA (2); Mecoprop (10); 
Methoxychlor (20); Metolachlor (10); Molinate (6); 
Pendimethalin (20); Simazine (2); 2,4,5-T (9); 
Terbuthylazine (7); Trifluralin (20) 
Drinking water Alachlor (2); Atrazine (3); Carbofuran (40); Chlordane (2); 
2,4-D (70); Dalapon (200); 2,4-dB (90); 
1,2-Dibromo-3-chloropropane (0.2); 1,2-Dibromoethane (5); 
1,2-Dichloropropane (5); Endrin (2); Glyphosate (700); 
Lindane (0.2); Methoxychlor (40); Oxamyl (200); 
Pendimethalin (20); Polychlorinated biphenyls (0.5); 
Simazine (4); Toxaphene (3); 2,4,5-T (50); Terbuthylazine 










Italy Environmental quality 
standards 




Australia Australian Drinking Water 
Guidelines 
Drinking water Acephate (8); Aldicarb (4); Aldrin and dieldrin (0.3); 
Ametryn (70); Amitraz (9); Amitrole (0.9); Atrazine (20); 
Azinphos-methyl (30); Benomyl (90); Bentazone (400); 
Bromoxynil (10); Captan (400); Carbaryl (30); Carbofuran 
(10); Chlordane (2); Chlorpyrifos (10); 2,4-D (20); 




Australia Australian Guidelines for 
Water Recycling: 





drinking water supplies 
Azinphos-methyl (3); Bromophos-ethyl (10); Carbendazim 
(100); Chlorpyrifos (10); Chlorpyrifos-methyl (10); 
Demeton-S (0.15); Diazinon (3); Dichlorvos (1); Dimethoate 
(50); Ethion (3); Ethoprophos (1); Fenthion (0.5); Malathion 
(900); Parathion (10); Parathion-methyl (100); 4,4′-DDT 
(20); 4,4′-DDE (20); Chlordane (1); Endosulfan sulfate (30); 
Lindane (20); Pentachlorophenol (10); 2,4-D (30); Alachlor 
(2); Atrazine (40); Cypermethrin (0.5); Diuron (30); 
Metolachlor (300); 4-Nitrophenol (30); 2-Phenylphenol 
(1000); Simazine (20); Thiophanate (5); Trifluralin (50); 




b. Surfactants  and 
PCPs 
EU Decision No. 2455/2001/EC and 
the Environmental Quality 
Standards Directive 
(2008/105/EC) 
















USEPA National Primary Drinking 
Water Regulations 
EU Decision No. 2455/2001/EC and 
the Environmental Quality 
Standards Directive 
(2008/105/EC) 
Australia Australian Drinking Water 
Guidelines 
Drinking water Acrylamide (0.5); Bromodichloromethane (60); Bromoform 
(100); Chloroform (300); Dibromoacetonitrile (70); 
Dibromochloromethane (100); Dichloroacetate (50); 
Dichloroacetonitrile (20); Epichlorohydrin (0.4); 
Monochloroacetate (20); N-Nitrosodimethylamine (0.1); 
Trichloroacetate (200); 2,4,6-Trichlorophenol (200); 
Vinylchloride (0.3) 
Drinking water Haloacetic acids (80); Total Trihalomethanes (100); Vinyl 
chloride (2) 
Bromodichloromethane (100); Bromoform (100); Chloroform 
(100); Dibromochloromethane (100)   
Drinking  water Acrylamide (0.2); Bromodichloromethane (250); Bromoform 
(250); Chloroform (250); Chlorite (800); Chloroacetic acid 
(150); Dibromochlormethane (250); Dichloroacetic acid 
(100); Trichloroacetic acid (100); N-nitrosodimethylamine 













Non-regulated DBPs: Chloronitromethane; Bromonitromethane; Dichloronitromethane; Dibromonitromethane; Bromochloronitromethane; Trichloronitromethane; 
Tribromonitromethane; Bromodichloronitromethane; Dibromochloronitromethane; Bromoacetic acid; Dibromoacetic acid; Iodoacetic acid; Bromoiodoacetic acid; 
(Z)-3-Bromo-3-Iodopropenoic acid; (E)-3-Bromo-3-Iodopropenoic acid; (E)-2-Iodo-Methylbutenedioic acid; Dichloroiodomethane; Bromochloroiodomethane; 
Dibromoiodomethane; Chloroiodomethane; Bromodiiodomethane; Iodoform; Dichloropropanone; Bromochloropropanone; Dibromopropanone; Trichloropropanone; 






Table 2 (continued) 
 
No.   Substance groups Legislative 
body 
  
Regulations Domain Substances1 (μg/L) References 
 
d. Solvents and other 
organic compounds 
 












Australia Australian Drinking Water 
Guidelines 
 
Drinking water Benzene (10); Carbon tetrachloride (4); 1,2-Dichlorobenzene 
(1000); 1,4-Dichlorobenzene (300); 1,2-Dichloroethane 
(30); 1,2-Dichloroethene (50); Dichloromethane (20); 
Di(2-ethylhexyl)phthalate (8); 1,4-Dioxane (50); Edetic acid 
(600); Ethylbenzene (300); Hexachlorobutadiene (0.6); 
Nitrilotriacetic acid (200); Pentachlorophenol (9); Styrene 
(20); Tetrachloroethene (40); Toluene (700); Trichloroethene 
(20); Xylenes (500) 
Drinking water Benzene (5); Benzo(a)pyrene (PAHs) (0.2); Carbon 
tetrachloride (3); 1,2-Dichlorobenzene (600); 
1,4-Dichlorobenzene (75); 1,2-Dichloroethane (5); 
1,2-Dichloroethene (7); Dichloromethane (5); 
Di(2-ethylhexyl)phthalate (6); Dioxin (0.00003); 
Ethylbenzene (700); Ethylene dibromide (0.5); Heptachlor 
(0.4); Heptachlor epoxide (0.2); Hexachlorobutadiene (0.6); 
Hexachlorobenzene (1); Hexachlorocyclopentadiene (50); 
Pentachlorophenol (1); Styrene (100); Tetrachloroethene (5); 
Toluene (1000); Trichloroethene (5); Xylenes (10,000) 
Drinking water Benzene (1); Carbon tetrachloride (4); 1,2-Dichlorobenzene 
(1); 1,3-Dichlorobenzene (20); 1,4-Dichlorobenzene (0.3); 
1,2-Dichloroethane (3); 1.2-Dichloroethene (60); 
















Australia Australian Guidelines for 
Water Recycling                 
2. Pharmaceuticals and steroid hormones 










drinking water supplies 
1,1-Dichloroethene (30); Coprastanol (0.7); 
1,7-Dimethylxanthine (0.7); Coumarin (0.5); 
2,5-Dihydroxybenzoic acid (7); Diatrizoate Sodium (0.35); 
2,6-di-tert-butyl-1,4- benzoquinone (0.014); Diatrizoic acid 
(0.350); 2,6-di-tert-butylphenol (2); Dibutyltin (2); 
4-Chlorophenol (10); Di-n-butyl phthalate (35); 
4- cumylphenol (0.35); Methylene chloride (4); 4-tert 
octylphenol (50); Monobutyltin (0.7); 
5- methyl-1Hbenzotriazole (0.007); Naphthalene (70); 
Anthracene (150); N-nitrosomorpholine (0.001); 
Acetophenone (400); Phenanthrene (150); Benzo(a)pyrene 
(0.01); Phenol (150); Benzyl chloride (0.2); Bisphenol A 
(200); Pyrene (150); Bromochloromethane (40); Tributyl 
phosphate (0.5); Butylated hydroxyanisole; Tributyltin (1); 
Caffeine (0.35); Tri(butyl cellosolve) phosphate (50); 
Chlorophene (0.35); Cholesterol (7); Triphenyl phosphate 
(1); 2,4,6-Trinitro-1,3- dimethyl-5-tertbutylbenzene (350); 
4-Acetyl-6-t-butyl-1,1- dimethylindan (7); 
6-Acetyl-1,1,2,4,4,7- hexamethyltetraline (4); Galaxolide 
(0.0018); Musk ketone (350); Musk tibetene (0.35); 
Pentamethyl-4,6- dinitroindane (0.35)  
Amoxycillin (1.5); Monensin (35); Anhydroerythromycin A 
(17.5); Naladixic acid (1000); Azithromycin (3.9); Norflaxin 
(400); Cefaclor (250); Penicillin G (1.5); Cephalaxin (35); 
Penicillin V (1.5); Chloroamphenicol (175); Roxithromycin 
(150); Chlorotetracycline (105); Sulfamethoxazole (35); 
Ciproflaxin (250); Sulfamethoxine (35); Clarithromycin 
(250); Sulfamethazine (35); Clindamycin (300); 
Sulfamethizole (35); Demeclocycline (300); Terramycin 
(105); Doxycycline (10.5); Tetracycline (105); Enrofloxacin 














Australia Aspirin (29); Indomethacin (25); Diclofenac (1.8); 
Ketoprofen (3.5); Dipyrone (vet) (525); Naproxen (220); 
Fenoprofen (450); Tolfenamic acid (vet) (17.5); Ibuprofen 
(400) 
Australia Betaxolol (10); Nadolol (20); Bisoprolol (0.63); Propranolol 
(40); Carazolol (0.35); Timolol (10); Metoprolol (25) 
Australia 17α-estradiol (0.175); Estriol (0.050); 17α-ethinyl estradiol 
(0.0015); Estrone (0.03); 17β-estradiol (0.175); Mestranol 
(0.0025); Equilenin (0.030); Norethindrone (0.25); Equilin 













Report on public health criteria 
for direct potable reuse 
systems (2013) 
Secondary treated 
effluent for direct 
potable reuse 
Estrone (0.32) Audenaert 
et al. 
(2014) 








Australia augmentation of 
drinking water supplies 
Alprazolam (0.25); Fluoxetine (10); Antipyrine (1000); 





Table 2 (continued) 
 
No.   Substance groups Legislative 
body 
  
Regulations Domain Substances1  (μg/L) References  
Bezafibrate (300); Iopamidol (400); Carbamazepine (100); 
Iopromide (750); Cimetidine (200); Isophosphamide (3.5); 
Clenbuterol (15); Metformin (250); Clofibric acid (750); 
Paracetamol (175); Codeine (50); Salbutamol (3); Cotinine 
(10); Salicylic acid (105); Cyclophosphamide (3.5); 
Sulfasalazine (500); Dehydronifedipine (20); Temazepam 







Report on public health criteria 
for direct potable reuse 
systems (2013) 
Secondary treated 
effluent for direct 
potable reuse 
Carbamazepine (10), Cotinine (1), Primidone (10), 
Phenyltoin (2), Meprobamate (200), Atenolol (4), Sucralose 




1   Regulated value (unit: μg/L) for each compound is presented in bracket (), for example: Simazine (20) means the required concentration of Simazine is 20 μg/L.   
content may interfere the adsorption of targeted contaminants. Activat- 
ed carbon shows a higher preference towards hydrophobic (log 
KOW N 4), low molecular weight, slightly positively charged compounds 
(at pH = 7–8) and compounds contain aromaticity and N-heterocycles 
(Table 4). 
Activated carbon technologies are preferred by EU countries as an 
upgrading option for their WWTPs because they can remove most of 
MPs in municipal WWTP effluents by 80%. In Germany alone, there 
are 14 WWTPs already adopting PAC/GAC technologies, six WWTPs 
under construction and three WWTPs under design (Mulder et al., 
2015). 
  
3.2.2. Advanced oxidation processes (AOPs) 
Oxidation methods aim to destruct and transform refractory sub- 
stances to simpler substances. Since traditional oxidation methods 
(i.e., Cl2, HClO, H2O2, KMnO4 and ClO2) are ineffective in tackling MPs, 
only advanced oxidation methods (AOPs) such as O3, UV/H2O2, O3/ 
H2O2, and UV/O3 are considered in full-scale applications. AOPs present- 
ed higher MP removal performance than traditional oxidation methods 
due to stronger oxidant doses, higher magnitude of free radical com- 
pounds hydrogen peroxy (HO2) and hydroxyl (OH), and longer contact 
time (Lee et al., 2009). An oxidation process is often governed by pH, 
temperature and water chemistry, as well as molecular structure and 
reactivity of substances (KO3 and K·OH). It is advisable that AOPs should 
be located between two biological processes to reduce the competition 
with other organic matters in the pre-treatment stage and degrade ox- 
idation by-products in the post-treatment stage. 
Beside PAC/GAC, ozonation is a preferable MP removal option in Eu- 
ropean. It is proven by the number of WWTPs applied ozone technology 
in Germany and Switzerland, including Wuëri WWTP with the capacity 
of 350 m3/h (Switzerland), Neugut WWTP 875 m3/h (Switzerland), Bad 
Sassendorf WWTP 300 m3/h (Germany), Duisburg-Vierlinden WWTP 
400 m3/h (Germany), Detmold WWTP 300 m3/h (Germany) and 
Schwerte WWTP 1100 m3/h (Germany) (Mulder et al., 2015; 
Audenaert et al., 2014). 
While UV alone is not effective in MP elimination, its combination 
with H2O2 or O3 can boost the formation of free oxidant radicals and 
thus, significantly improve the removal rate (Kruithof et al., 2007; 
Yang et al., 2014). O3/UV has the highest oxidation potential and ex- 
hibits two-tier barriers for contaminants. This is because O3 has greater 
UV adsorption capacity by a magnitude of 200 times (at 254 nm) than 
an equivalent amount of H2O2 does (Sarathy and Mohseni, 2008). How- 
ever, its high energy consumption inhibits a widespread application of 
O3/UV in reality. To date, UV/H2O2 is still the most popular UV-based 
AOP in large-scale. H2O2/O3 is considered the most energy-efficient 
AOP and is more suitable for water with poor UV light transmission 
(Lee et al., 2009). 
3.2.3. Membrane processes 
Applicable membrane processes are microfiltration (MF), ultrafiltra- 
tion (UF), nanofiltration (NF) and reserve osmosis (RO). MF and UF are 
frequently used to support other MP treatment technologies rather than 
being used per se because their membrane pores are larger than MP 
molecular sizes. Filtration and adsorption on the membrane are the 
key removal mechanisms for membrane processes. The rejection rate 
depends on both MPs (molecular size and weight, charge and hydro- 
phobicity) and membrane characteristics. With its smallest membrane 
pore sizes, RO is the most effective membrane process to remove MPs, 
even those substances unable to eliminate in MBRs such as diclofenac, 
carbamazepine, fenoprop, metronidazole and trimethoprime (Hai et al., 
2011). Conversely, membrane processes are less sensitive to neutral 
compounds such as Bisphenol A, NP, NDMA, 17β-estradiol, and caffeine 
(Lee et al., 2009). Consequently, the combination of GAC/PAC and mem- 
brane processes are recommended to get a better performance. 
 
3.2.4. Membrane bioreactors (MBRs) 
MP removal of MBRs largely relies on (i) microorganism consortia to 
metabolise MPs and (ii) sorption capacity of sludge and (iii) rejection 
rate of membrane. Extended sludge retention time (SRT) may foster a 
more diverse microorganism structure which enhances MP removal 
(Hai et al., 2014). The outperformance of MBR over conventional acti- 
vated sludge treatment in MP removal is explained in Fig. 1. 
The comparison between conventional aerobic processes and MBRs 
has been carried out by various authors. For example, Bernhard et al. 
(2006) found that MBRs had a better removal efficiency towards 
diclofenac, mecoprop and sulfophenylcarboxylates. In a different 
study, de Wever et al. (2007) confirmed that MBRs significantly im- 
proved the elimination of, 6- and 2,7-naphthalene disulfonate (NDSA) 
and benzothiazole-2-sulfonate. Although MBRs have higher MP remov- 
al rates than conventional aerobic biological treatment methods, they 
are not effective in removing (i) compounds with long, highly branched 
side chains, (ii) saturated/polycyclic compounds, and (iii) compounds 
having electron receptive functional groups or sulphate and halogen 
such as diclofenac, carbamazepine, DEET and trimethoprim (Lee et al., 
2009). In addition, microbial community is also subject to toxicity of 
some recalcitrant substances (Cazes et al., 2014). Despite a huge 
amount of papers tried different methods to improve the efficiency of 
MBRs in removing MPs, the majority of them are done at laboratory 
scale. 
 
3.3. Environmental  considerations 
 
3.3.1. Activated carbon adsorption 
The basic principle of adsorption process is to move MPs from liquid 
phase to solid phase. Compared to advanced oxidation, activated carbon 




Case studies for assessment. 
 
No.   Method Medium Treatment 
purpose 
   
Targeted pollutants Scale Treatment traina Capacity Reference 







Algae toxins (microcystine), 
endocrine  disruptors  (bisphenol 
A), fuel oxygenates (MTBE), 
pesticides (atrazine, pyrazon, 
diuron, bentazone, bromacil, 
dicamba, 2,4-D, TCA, trichlorpyr, 
methabenzthiaxuon, 
desethyl-desisopropylatrazine), 
oxidation by-products (NDMA), 
solvents  (dioxane), 
pharmaceuticals  (diclofenac, 
ibuprofen) 
Pilot/Full-scale    IJssel Lake → Coagulation → 
Rapid sand filtration → 
UV/H2O2  treatment → GAC 
filtration → GAC filtration → 








Kruithof et al. 
(2007) 




Drinking water Organic MPs (24) Pilot/Full-scale   N/A N/A Kennedy et al. 
(2015) 















and fire fighting 
Biocides and pesticides (10), 
pharmaceuticals (24), 
transformation products (7), 
X-ray contrasting media (6), 
corrosion inhibitors (2), 
nitrosamines (8) 
387 substances: nitrosamines 
(5), endocrine disrupting 
compounds (20), 
pharmaceuticals (58), phenoxy 
herbicides (11), haloacetic acids 
(9), herbicides (51), 
organochlorine pesticides (33), 
organophosphorus pesticides 
(46), other pesticides (25), 
synthetic pyrethroids (12), other 
compounds (20), phenolics (18), 
polycyclic aromatic 
hydrocarbons (pahs) (30), 
trihalomethanes (5), iodinated 
halomethanes (5), 
perfluorinated compounds (17), 
aldehydes (4), disinfection 
by-products (11) 
Full-scale Primary sedimentation → 
Activated sludge treatment 
→ Sedimentation → 
Ozonation → Sand filtration 
→ Discharge 
Full-scale Pre-ozone → Biological 
media filtration → 


















Blackbeard et al. 
(2016) 
5. GAC Sewage 
wastewater 




diclofenac, meclofenamic acid, 
monensin 
Full-scale Screens → Primary 
sedimentation → Activated 
sludge → Secondary 













Reuse Steroidal hormones, 
xenoestrogens, pesticides, 
caffeine and pharmaceuticals 
and personal care products 
(PPCPs) 
Full-scale Screens → MBR → UV → 














Pharmaceuticals Full-scale Screens → Primary 
settlement → MBR → 
Advanced treatment → 




Q = 130 
m3/d 








Pharmaceuticals (17) and trace 
organic pollutants (22) 
Pilot 3 different processes: 
1. Integrated   fixed-film 
activated sludge MBR 
(IFAS-MBR) + RO 
2. Moving bed MBR 
(MBMBR) + RO 
3. MBR + RO 





Wastewater  Wastewater 
discharge 
Tetracycline Pilot N/A 1043 L/m2.h Abejon et al. 
(2015) 
10. Activated carbon Wastewater    Wastewater 
discharge 









+ GAC (dual filter) 
0.6 m3/h Meinel et al. 
(2014) 






Antibiotics, EDCs Pilot Secondary effluent → 
Denitrification biofilter → 
0.6 m3/h X. Li et al. (2015) 
 
 
Table 3 (continued) 
 
No.   Method Medium Treatment 
purpose 
  
Targeted pollutants Scale Treatment traina Capacity Reference 
  
12. Microfiltration 






Water reuse Pharmaceuticals (29) and 
pesticides (20) 
 
Ozonation reactor → 
Biological aerated filtration 
Pilot Secondary effluent → UV → 
Microfiltration → RO 
  
2 m3/h Rodriguez-Mozaz 
et al. (2015) 







Pharmaceuticals (21) Pilot Activated sludge (or 
biofilm) → Ultrafiltration 
0.9 m3/h Mousaab et al. 
(2015) 






Diethylphthalate Pilot Wastewater → AC → O3 5–20 L/h Chedeville et al. 
(2014) 
15. Nanofiltration 










ibuprofen, ofloxacin and 
sulfa-methoxazole 
Pilot 1. WWTP effluent → 
pre-filtration  → NF 
2. WWTP effluent → 
pre-filtration → solar 
photo-Fenton 
100 L/h Miralles-Cuevas 








Tetracycline Pilot Batch  experiment: 
Wastewater → MBR 
N/A de Cazes et al. 
(2014) 
17. Powdered PAC Municipal 
wastewater  
 








Pharmaceuticals and hormones 
(54) + other emerging 
pollutants (59) 
 
EDCs, herbicides, pesticides, 
volatile pesticides, NDMA 
Pilot [Screening → Grit and oil 
removal → lamellar settling 
unit with coagulation → 
3-stage bio-filters] → PAC 
Pilot Conventional  activated 
sludge (CAS) treated 
wastewater → pre-filter → 
MF → RO → H2O2/UV 
6–12 m/h Mailler et al. 
(2015)   











Pilot [Screening → Grit removal 
→ Fine screening → SBR 




Lowenberg et al. 
(2014) 
Note: N/A: non-assessment. 
a   Processes presented in bracket […] are pre-treatment for the experiment's influent.  
consumption and no by-product formation. However, spent adsorbents 
which contain adsorbed MPs are considered hazardous waste and must 
be managed properly. 
 
3.3.1.1. GAC. For GAC filters, MP removal is greatly affected by the fre- 
quency of adsorbent replacement or regeneration. Despite GAC can be 
reused, its regeneration demands high energy demand for production 
of hot steam to desorb high-molecular-weight pollutants. The desorbed 
stream should be managed as hazardous waste. In addition, due to the 
weakly attachment of some MPs on GAC as well as competition from 
NOMs, several MPs such as MTBE tends to desorb back to the solution 
(Creek and Davidson, 2000). 
 
3.3.1.2. PAC. Unlike GAC, PAC cannot be regenerated. Therefore, extend- 
ing PAC life-time by recycling it into biological treatment tanks is crucial 
to utilise its full capacity. The return of PAC into aerobic tanks may boost 
the MP removal performance by 5–10% (Grover et al., 2011). Neverthe- 
less, PAC addition (10–20 g PAC/m3) increased the sludge volume by 5– 
10% (Margot et al., 2013). Exhausted PAC must be separated from 
wastewater by sand filtration or membrane processes. To reduce de- 
sorption of contaminants from adsorbents back to liquid phase, mem- 
brane processes are preferred over sand filtration although sand 
filtration post-treatment is more economical (Margot et al., 2013). 
Wasted PAC must be finally incinerated or disposed as hazardous waste. 
 
3.3.2. Advanced oxidation processes (AOPs) 
The ultimate concern in AOP applications is that AOPs do not 
completely get rid of MPs but transform them into simpler compounds 
(Verlicchi et al., 2015). Unfortunately, some of those compounds react 
with other chemicals (bromides) or DOC presented in wastewater and 
create new intermediates such as bromate, nitrosamines, chloral hy- 
drate and carbonyl (Blackbeard et al., 2016; X. Li et al., 2015). The 
transformation process is unpredictable as it is strongly influenced by 
specific water matrix, pH and DOC content (Hollender et al., 2009). 
  
3.3.2.1. Ozonation and ozone-based AOPs. After an ozonation process, 
Blackbeard et al. (2016) observed a formation of atrazine by-products 
(desisopropyl atrazine and desethyl atrazine), a two-fold increase in 
NDMA (from 15.3 ng/L to 31.4 ng/L), and especially, a 40-time amplifi- 
cation of bisphenol A. Some transformation products may be more toxic 
than their precursors. X. Li et al. (2015) found the inhibitory rate on 
Vidua fischeri increased from 9% (prior to ozonation) to 15% (after ozon- 
ation). Further treatments such as sand/biological filtration (X. Li et al., 
2015) or UV (Siegrist and Joss, 2012) are exploited to reduce these com- 
pounds as well as their toxicology. 
Ozone production process consumed a huge amount of energy with 
a low efficiency of conversion when the maximum concentration of 
ozone produced in air or oxygen was only 1–2% or 4–8%, respectively 
(Derco et al., 2015). Ozone generation firstly required an energy-inten- 
sive production of absolutely dry air or oxygen (0.01–0.015 kWh per m3 
of pure oxygen produced) (Hollender et al., 2009). In addition, the ener- 
gy demand for 1 kg of O3 produced from process gas having 100–170 g 
O3 per m3 is 12 kWh, excluding the oxygen production process 
(Hollender et al., 2009). About 85% of the consumed energy is wasted 
as heat and needed to be eradicated to protect the reactor from over- 
heating. 
Ozone has a short life cycle. While its theoretical half-life time is 3– 
8 days in air or 15–20 min in water at 20–25 °C; its actual degradation 
rate can range from seconds to hours, depending on water temperature, 
pH, DOC and ozone scavengers (Lenntech, 2016). As such, O3 must be 
generated onsite (Derco et al., 2015). Additionally, ozone handling 
yields potential fire hazards and toxicity issues. Because ozone is a 
strong oxidant, it may cause respiratory problems for workers when 






















Operational factors Physical-chemical characteristics of substances 
High efficiency 
















• Dosage •  Leading operational fac- 
tor 
• Optimal PAC dose 
=10–20 mg/L. Higher 
dosages (40–50 mg/L) 
may result in higher re- 
moval rate. 
• Contact time •  Higher contact time, 
higher efficiency 
• Optimal ≥ 30 min 
• Charge at pH = 








Slightly positively charged 




LogKow N 4: tamoxifen, 
indomethacine,  diclofenac, 
meclofenamic acid 
Slightly negatively charge 




2.5 b LogKow b 4: monensin LogKow b 2.5: sulfamethoxazole, 
propranolol 
Mailler et al. 
(2015), Altmann 
et al. (2014) 
  
  
Mailler et al. 
(2015), Altmann 
et al. (2014) 
• pH •  Affect the charge of hy- 
drophilic compounds 
• Optimal pH = 7–9 
•   Acid dissocia- 
tion constants 
(pKa) 
pH N pKa: sulfamethoxazole Nam et al. (2014) 
•    Wastewater 
composition 
•  Other organic matters 
may compete adsorption 
sites with MPs (DOC 
≤ 5–10 mg/L) 




show less com- 
petition with 
natural matters 
Lower molecular size Large molecular size: erythromycin, 
roxithromycin 
Mailler et al. 
(2015) 
• Structure and 
functional 
group: polariz- 
ability or struc- 
ture of the 
compound 
Compounds contain aromaticity 
and N-heterocycles: ofloxacin, 
diclofenac 
Saccharin, DEHP, bisphenol A      Halogenated aliphatic: iodinated 
contrast media, acesulfame, sucralose, 
triclosan, perfluorooctane sulfonate, 
nonylphenol 





processes  (O3 
and  O3-based 
processes, 
UV/H2O2) 
• Oxidation •  Dosage •  Higher dosage, higher re- 
moval rate 
• Can form by-products 
• O3 is less reactive to- 
wards organic and inor- 
ganic matters 
• Dosage = 0.2–0.6 mg 
O3/mg DOC or 3–8 mg 
O3/L 
• pH •  Influence the reactivity 




• Reactivity with 
O3 (kO3) or •OH 
radical (k •OH) 
Contains unsaturated double bonds 
(trimethoprim,  carbamazepine) 
and/or electron donating properties 
(diclofenac, macrolides and 
sulfonamide antibiotics) 
   
Chemicals with high reaction rates 
with ozone 
Mostly alkyl aromatics, 




Chemicals with moderate 
reaction rates with ozone 
and/or •OH radical 
Mostly primary amines and nitro 
groups, amides, saturated aliphatic or 
halogenated aliphatic: bezafibrate 
    
 
Chemicals with lower reaction rates 
with ozone and/or ••OH radical 
Blackbeard et al. 
(2016), Luo et al. 
(2014), Altmann 
et al. (2014), 
Margot et al. 
(2013) 
   






• Compete with targeted 
MPs • kO3 N 10




• kO3 b 10 M−1 s−1 and k•OH 
≥ 5 × 109 M−1 s−1: 
•  109 M−1 s−1 b k•OH b 5 × 109 M−1 
s−1: 2,4-D, atrazine, simazine, 
iopromide, 















• Polyamide often have a 




weight and size 
tramadol, venlafaxine, metoprolol, 
atenolol    
RO: MW ≥ 200 g/mol: most 
pharmaceutical compounds, 
and primidone (chloroethyl)phosphate, 
perfluorooctanoic acid, tris 
(chloropropyl) phosphate isomers, 
tris (dichloro-propyl) phosphate, io- 
dinated contrast media 





Siegrist and Joss 
(2012), 
(continued on next page) 
  




      
    
     
    
 
 









   
 
 






















Operational factors Physical-chemical characteristics of substances 
High efficiency 
















off, pore size, 
surface 
(57–91%) 
• Surface charge of a 
membrane will affect the 
macrolides, cholesterol and some 
pesticides (tertbutylazine, diazinon, 
MCPA and mecoprop) 
mefenamic acid Rodriguez-Mozaz 








• Other opera- 
tional 
parameters 
= 10–80 days) 
• It is recommended to 
read more in the review 
of Hai et al. (2014) for 
more thorough under- 
standings since results 
from different experi- 








High hydrophobicity (log D N 3.2): 
estrone, nonylphenol, triclosan  
MW N 300 g/mol: most 
pharmaceutical   compounds, 
macrolides,  cholesterol  and 
pesticides 
 
Log D b 3.2: depend on its 
biodegradability: anticorrosive 
benzotriazoles, carbamazepine 
MW b 300 g/mol: depends on 
biodegradability 
 
Tadkaew et al. 
(2011) 
 
Tadkaew et al. 
(2011) 
contradictory. • Biodegradability   Linear, with short side chains; 
unsaturated  aliphatic  compounds; 
have electron donor functional 
groups:  steroidal  hormones 
(androstenedione,  androsterone, 
etiocholanolone, dihydrotestosterone, 
testosterone, 17β-estradiol, estriol), 
xenoestrogens (estrone, bisphenol A, 
propylparaben),   pharmaceuticals 
and PCPs (atenolol, atorvastatin, 
DEET, ibuprofen, ketoproen, 
metformin, naproxen, triclosan, 
caffeine, o -hydeoxyAatorvastatin, 
paracetamol) 
Contain both electron donor 
functional groups and 






Long with highly branched side 
chains; saturated or polycyclic 
compounds;  have  electron  receptive 
functional groups or sulfate and 
halogen: carbamazepine, dilantin, 
phen, linuron, atrazine, DEET, 
meprobamate, diazepam, diclofenac, 
fluoxetin 
Trinh et al. 
(2012), Tadkaew 




Fig. 1. Improved MP removal mechanisms of MBR in comparison with conventional activated sludge treatment (adapted from (Hai et al., 2014)).  
Work Australia, 2015). Thus, sufficient training for people working with 
ozone is necessary. 
Furthermore, despite O3 has a high solubility in water (109 mg/L at 
25 °C), its highly reactivity with pollutants and itself makes it difficult 
to get a homogenously dissolved ozone concentration. This challenge 
demands a strong mixing power to maximise contact between oxidants 
and targeted substances in a short time. As Hollender et al. (2009) cal- 
culated, the power rate for treating 1 m3 of wastewater with DOC con- 
centration of 5 g/m3 and ozone dose of 0.6 g O3/m3 is 0.035 kWh. This 
value is slightly lower than those in a Swiss study of 0.06 kWh/m3 for 
the dose of 5 g O3/m3 (Joss et al., 2008). 
 
3.3.2.2. UV/H2O2. H2O2 has several advantages over O3 when it is more 
stable and can be kept onsite for a long period of time prior to usage 
(Lee et al., 2009). Kruithof et al. (2007) studied the application of UV/ 
H2O2 for both disinfection and MP removal in the Andijk surface water 
treatment plant and found that the corresponding UV dosage for MP re- 
moval was much higher (540 mJ/cm2) than those required for disinfec- 
tion (120 mJ/cm2) with the optimal peroxide dose of 6 mg/L. This 
treatment process was proven to be robust and reliable. It can also re- 
duce the formation of oxidation by-product NDMA to under 10 ppt 
(Sarathy and Mohseni, 2008). Nevertheless, the residual H2O2 must be 
removed before discharging. 
 
3.3.3. Membrane processes 
Reserve osmosis has several critical pitfalls. Membrane fouling is the 
most serious challenge in membrane operation. To control membrane 
fouling, chemical cleaning by chloramine is necessary to remove fouling 
layers. The reaction between the disinfectant chloramine and NDMA- 
precursors in water could result in formation of NDMA (Siegrist and 
Joss, 2012). Moreover, RO often requires a substantial amount of 
power to pump water through membrane pores. 
Last but not least, RO often produce a large volume of highly concen- 
trated waste stream which enquires further treatment and disposal 
(Siegrist and Joss, 2012). The waste stream can take account of 35% of 
the influent flow and is 4–10 times more concentrated than the influent 
concentration (Rodriguez-Mozaz et al., 2015; Chelme-Ayala et al., 
2009). Treatment of concentrate still remains a big challenge for opera- 
tors. Although some advanced oxidation methods were tested for brine 
treatment, their practical applications are not economically feasible. 
Therefore, current management method is still to discharge to waste 
management or evaporating facilities (Rodriguez-Mozaz et al., 2015). 
Since the most challenging operation issues of RO are severe mem- 
brane fouling and high energy consumption, NF can be a low-pressure 
alternative with a comparable efficiency (Yangali-Quintanilla et al., 
2011). 
 
3.3.4. Membrane bioreactor (MBR) processes 
The most outstanding advantage of MBRs is the complete elimina- 
tion of many MPs from the water rather than being transferred to a dif- 
ferent phase (as in activated carbon processes), concentrated waste 
stream (membrane processes) or by-products (AOPs). Nevertheless, 
MBR may also produce some biotransformation products. MBRs can 
also provide an effluent free of microorganisms and suspended solids 
with low concentration of BOD. Conversely, the main concern of using 
MBR is also membrane fouling. The presence of MPs may contribute to 
higher degree of irreversible membrane fouling (C. Li et al., 2015). The 
second issue relating to MBR application is the treatment of wastewater 
concentrate and sludge that contain MPs. Lastly, nearly 85% of energy 
consumed in MBR treatment plants is related to aeration and pumping 
(Hai et al., 2014). 
 
3.3.5. Summary 
The environmental consideration of advanced treatment methods 
are summarised in Table 5. 
 
3.4. Technological considerations 
 
Five technological aspects are considered in this section, including 
(i) ease of construction and set-up, (ii) flexibility to adapt to the fluctu- 
ation in influent water characteristics and flow-rate, (iii) reliability of 




3.4.1. Activated carbon 
 
3.4.1.1. GAC. GAC has a long history of application in real-world water 
treatment plants. It is a simple, flexible and reliable treatment method. 
GAC can be (1) added into existing filters as an additional layer or (2) 
worked in a separate GAC filter. Two important parameters of GAC op- 
eration are breakthrough capacity and operating time (Lee et al., 2009). 
With an empty bed contact time of 20 mins, theoretically operating du- 
ration of hydrophobic and hydrophilic compounds before saturation are 
70,000 and 2000–3000 bed volumes, respectively (Lee et al., 2009). 
However, in reality, this figure is much lower as materials are deterio- 
rated gradually as number of cycles increased and competing organic 
matters. The remarkable operational problems of GAC filters are clog- 
ging of backwash and surface wash nozzles. Its remediation measures 
are clearly presented in the literature. 
  
3.4.1.2. PAC. Similar to GAC, PAC is very flexible when it can be added 
into existing infrastructures (for example, biological tanks) or into a 
new contacting tank (Lowenberg et al., 2014). Its simplicity in operation 
is well documented. In spite of this, there are some troubles in the pro- 
cedure of adding PAC into water. PAC is often stored onsite in silos and 
then being introduced to a dosage system where PAC is mixed with 
water before being supplied to treatment tanks. Due to the abrasion na- 
ture of the slurry PAC mixture, transporting pipelines can be eroded and 
clogged (Mulder et al., 2015). In addition, fire hazards from PAC dust 
should be taken into account. 
Last but not least, separation of exhausted PAC is problematic for 
plant operators. There are two common methods to remove PAC – 
sand filters and UF. Sand filters are often cheaper to operate but UF is 
more effective to prevent desorption of MPs from PAC back to water 
(Lowenberg et al., 2014). 
3.4.2. Advanced oxidation 
 
3.4.2.1. O3 and O3-based AOPs. As analysed in Section 3.3.2, the ozone 
generation process has a very low productivity; therefore, key technical 
considerations of ozone treatment are to remain (i) a very effective 
mass transfer from gas to liquid phase and (ii) an efficient contacting 
chamber. Ozonation is correspondingly subject to the presence of O3 
scavengers, so its removal performance can be deteriorated significantly 
when influent BOD, COD and SS increased (Environmental Technology 
Initiative, 2016). 
Ozonation processes usually require complicated equipment to pro- 
duce, control and post-treatment of residual ozone in off-gas. Several 
operational issues such as (i) feed air quality, (ii) a constant and stable 
coolant supply to counteract ozone generator over-heating, (iii) regular 
inspection and maintenance of ozone generators necessitate advanced 
operational skills (Environmental Technology Initiative, 2016). There- 
fore, it may not be feasible in small plants with non-permanent staff 
(Margot et al., 2013). 
 
3.4.2.2. UV/H2O2. Compared to O3-AOPs, UV/H2O2 requires less invest- 
ment but it involves a specially designed reactor to accommodate UV. 
This method is not suitable for water with low UV transmission because 
H2O2 has a low UV absorbance capacity (Lee et al., 2009). The use of UV/ 
H2O2 need to consider the following factors (KFR, 2011): 
 
• UV dose and H2O2 dose: these are crucial factors for the reactor design. 
The applied doses depend on UV lamp output, hydraulic conditions 
and residence time. 
• The choice among different technologies medium pressure UV/H2O2, 
low pressure UV/H2O2 and dielectric barrier discharge UV/H2O2. De- 
tailed discussion on their advantages and disadvantages could be 




Environmental considerations of advanced treatment methods. 
 













&  pumping 
• Low ener- 
gy 
consumption •  Low energy 
consumption,  except 
for  onsite  regeneration 
of GAC (only feasible if 
annual GAC consump- 
tion ≥ 150,000 kg) 
• High energy 
consumption 
+ 0.01–0.015 kWh/m3 
O2 
+ O3  production & 
control: 12 kWh/kg O3. 
85% of energy is wasted 
in form of heat. 
+ treatment process: 
0.212 kWh/m3 
wastewater 
• High energy 
consumption 
+ UV dose for MP removal 
is 5–6 times higher than 
being used for disinfection 





• None •  None •   Potential fire hazards 
and toxicity risks of O3 
handling 
• None •  Chemicals for membrane 
cleaning 
• Chemicals for 
membrane 
cleaning 
By-products •  None •  None •   Formation of by-- 




• May be toxic 
• Formation of by-- 
products such as 
ketones, carboxyl, 
aldehydes, etc. 
• Residual H2O2 must 
be treated 
• Formation of by-- 
products such as NDMA 
due to using chloramine 









• Disposal of 
used PAC 
• Spent GAC required regeneration 
or replacement 
• None •  None •  Treatment of 
concentrate 







Technological considerations of advanced treatment methods. 
 




PAC GAC O3 and O3-AOPs UV/H2O2  
Ease of 
construction 




• Easy to construct, install 
and incorporate 
• O3 applications require compli- 
cated apparatus & efficient 
contacting systems. 
• Special reactor de- 
sign for UV radiation 
• Commercially 
available 
• Commercially avail- 
able in the form of 
modules 
Flexibility •   Highly flexible 
• Can be applied 
as needed 
• Flexible •  Be affected greatly by influent 
COD, BOD and SS 
• Not applicable for 
low UV-transmission 
wastewater 
• Be subject to 
pre-treated 
water quality 
• Can accommodate a 
wide range of influ- 
ent fluctuation 
Reliability •   Lower efficiency 
in the presence 
of DOC 
• Lower efficiency in the 
presence of DOC 
• Difficult to predict the forma- 
tion of by-products 
• Inefficient for wastewater with 
high O3 scavengers 
• Difficult to predict 
the formation of 
by-products 
• High quality 
effluent 





• Simple operation •   Require professional proficient 
• Ozone in off-gases from contact 
chamber must be removed. 
• Retain O3 contact with MPs 
• Require professional 
proficient 





• Require professional 
proficient 
• Membrane cleaning 
Maintenance 
requirements 




• O3 is a very corrosive and reac- 
tive substance → require high-- 
quality materials 
• UV lamp & dosage of 
H2O2 
• Severe mem- 
brane fouling 
• Severe membrane 
fouling 
  
between these methods in a  similar operating condition decreases in 
the following order: medium pressure UV/H2O2 N dielectric barrier 
discharge UV/H2O2 N low pressure UV/H2O2. Application of medium 
pressure UV/H2O2 at the dosage  of  450  mJ/cm2  eliminated  about 
80% of MPs (KFR, 2011). 
   
3.4.3. Membrane processes 
Membrane fouling is the critical operational issue of membrane pro- 
cesses, especially RO. Membrane fouling types and causes are reviewed 
extensively in the literature (Guo et al., 2012). RO operation relies great- 
ly on influent pre-treatment. In a survey of eight full-scale RO plants for 
water reclamation in Spain, Lazarova et al. (2008) found that poor pre- 
treated water quality may decrease membrane lifetime by 60–75%. The 
main fouling mechanism was organic fouling and biofilm formation on 
membrane surface (Lazarova et al., 2008). Polyamide is more sensitive 
to bio-fouling than other membrane materials. Therefore, operation of 
membrane processes demands professional proficient to (i) properly 
report system data (membrane cleaning/replacement schedule, system 
flow, pH, pressure difference, turbidity and conductivity) and quality of 
feed, permeate and concentrate, (ii) analyse monitored data to com- 
mence repair or corrective maintenance, (iii) predict fouling types and 
time to clean or replace membrane to ensure a desired flux. 
because each treatment train is unique to its design criteria (WWTP's 
serving size, wastewater characteristics, targeted pollutants, removal 
requirements and specific site conditions) and operating conditions. 
As presented in Sections 2.1 and 3.2, ozone and activated carbon ad- 
sorption are the preferential methods for MP removal in the pioneering 
European countries. Consequently, information on their financial ap- 
praisal is rather sufficient whereas economic assessment on membrane 
processes and MBRs is hardly available. Therefore, this section will dis- 
cuss the cost analysis of these methods in detail. The framework for eco- 
nomic assessment of three common treatment methods (GAC, PAC/ 
sand filtration, O3/sand filtration) is presented in Fig. 2. 
 
3.5.1. Activated carbon adsorption and ozonation 
In this section, a majority of raw data was taken from Mulder et al. 
(2015) and will be assessed against other studies (see Table 7). 
 
3.5.1.1. Activated carbon adsorption. Despite activated carbon adsorption 
is simple to establish and operate, it bears a high capital investment and 
variable costs. The general design parameters for different studies are 
 
Table  
General design parameters for PAC + sand filter from experience of Germany, Switzerland 
and the Netherlands (data adapted from (Mulder et al., 2015)). 
 
PAC Germany and Switzerland Netherlands  
3.4.4. Membrane bioreactors Dosage 0.7–1.4 g PAC/g DOC 10–20 mg PAC/L 
 
1.1 g PAC/g DOC 
12 mg PAC/L 
The membrane bioreactors have been applied widely in recent years, 
mostly in small-scale WWTPs. Although they can accommodate a wide 
range of influent fluctuation and attract interests from scientists, MBRs 
are still considered a risky and costly alternative for MP removal 
(Radjenovic et al., 2008). It requires highly skilled staff to operate. Addi- 
tionally, membrane fouling in MBRs is very severe. The research carried 
out by C. Li et al. (2015) confirmed that some long-chain MPs such as 
carbamazepine can significantly increase the membrane fouling. 
Dosage coagulant 4–6 mg/L 5 mg/L 
Dosage polymer 0.2–0.3 mg 100%active/L 0.2 mg 100%active/L 
HRT 30–40 min 35 min 
Surface load settler 2.0 m/h 2.0 m/h 
PAC recycle rate 0.5–1.0 0.8 
Power consumption 45 W/m3 treated water 45 W/m3 
Sand filtration after PAC 
Upflow velocity 12 m/h 
Backwash water 5–10% of influent 
Power consumption 15 W/m3 treated water 15 W/m3 
GAC Germany and Switzerland Netherlands 
3.4.5. Summary 
To sum up, main technological aspects from the selected treatment 
Empty bed contact 
time 
20–40 min 30 min 
methods are presented in Table 6. Upflow velocity 6–10 m/h 8 m/h  
3.5. Economic assessment 
Replacement rate After 7000–20,000 bed 
volumes 
(every 4 months–1 year) 
8800 bed volumes (6 
months) 
 
It is very difficult to make a direct comparison between these alter- 
natives in different countries, and sometimes even in the same country, 
 
Power consumption 40 W/m3 treated water 40 W/m3 
Backwash water 5–15% of influent 10% 




General design parameters for ozone/sand filter from experience of Germany, Switzerland 
and the Netherlands (data adapted from (Mulder et al., 2015)). 
 
Germany and Switzerland Netherlands 
 
Dosage 0.6–0.9 g O3/g DOC 
4–14 mg O3/L 
(based on DOC = 7–15 mg/L) 
HRT 15–30 min 
(reactor 10–25 min + removing 
remaining O3 5 min) 
 
0.7 g O3/g DOC 
7.7 mg O3/L  
25 min 
Power consumption for O3 
production 
Power consumption for 
water treatment 
Sand filtration after O3 
10 kWh/kg O3 10 kWh/kg O3  
45 W/m3 45 W/m3 
Upflow velocity 12 m/h 12 m/h 
Backwash water 5–10% of influent 5% 
Power consumption 15 W/m3 treated water 15 W/m3 
treated water   
presented as follows, based on the frequently observed WWTP 
effluent's DOC = 7–15 mg/L. The increase in DOC concentration will re- 
duce the performance of PAC/GAC adsorption and require higher dos- 
ages, which in turn increase operational costs. 
The onsite regeneration of GAC is so costly that it is only feasible 
when the carbon capacity is larger than 150,000 kg per year (Lee et 
al., 2009). 
 
3.5.1.2. Ozonation. The operation and maintenance costs for ozone treat- 
ment consist of energy, chemicals and supplies, equipment repairs, and 
personnel requirements. The investment cost of upgrading WWTPs 
with an add-on ozonation step in Switzerland increases by 10–20% for 
large-scale ones and 20–50% for small- and medium-scale ones while 
energy consumption raised by 5–30% (Eggen et al., 2014). The general 
design parameters for ozone treatment are presented in Table 8. 
 
3.5.1.3. Comparison between activated carbon adsorption and ozonation. 
The MP removal costs for one m3 of WWTP effluent of three alternatives 
(i) Ozone + sand filtration, (ii) PAC + sand filtration and (iii) GAC filtra- 
tion are illustrated in Fig. 3. These alternatives are proposed for three 
categories of WWTPs, including (1) small-scale WWTPs serving 
20,000 people with the dry-weather wastewater flow-rate 200 m3/h, 
(2) medium-scale WWTPs for 100,000 people with the design flow- 
rate 1050 m3/h, and (3) large-scale WWTPs for 300,000 people with 
3100 m3/h. The MP post-treatment cost with ozone and PAC technolo- 
gies ranged €0.22–0.26/m3 (equivalent to 0.24–0.31 USD/m3) for 
small plants and significantly reduced to €0.16–0.18/m3 (0.17–0.20 
USD/m3) for large-scale plants (Table 9). GAC is the most expensive op- 
tion and its treatment cost has only been reduce slightly from small- 
scale to large-scale plants. GAC's variable costs were extremely high, 
which took account 65–75% of its annual expenditure. Interestingly, 
its capital investment is only a half of those of ozone and PAC 
treatments. 
In this study, ozone with sand filtration was the most economical 
option in all scales of treatment; yet PAC with sand filtration is a compa- 
rable option for large-scale plants. This finding was in harmony with the 
calculations of Joss et al. (2008) in Switzerland (€0.15–0.20/m3), 
Roccaro et al. (2013) in Italia (€0.30–0.40/m3) and Wahlberg et al. 
(2010) in Sweden (€0.15–0.30/m3). The combination between PAC 
  
   
Fig. 2. Economic assessment framework for GAC, PAC and ozone treatment with available 
information from Germany, Switzerland and the Netherlands. 
  
and UF can significantly increase the operational cost (Margot et al., 
2013). 
 
3.5.2. Comparison with other treatment processes 
Due to the lack of information on economic evaluation from the 
other treatment processes, Fig. 4 was provided as a rough estimation 
for the relativity between MP treatment methods. It presented the re- 
sults from Stockholm Water Company's four-year project “Pharmaceu- 
ticals - Presence and effects in the aquatic environment, preventive 
measures and possible treatment methods”, reported by Wahlberg et 
al. (2010). 78 out of 90 studied pharmaceuticals were found in 
WWTPs' influents, such as hydrochlorothiazide, amiloride, propranolol, 
metoprolol, atorvastatin, amlodipine, to name just a few. In this figure, 
the residues left after treatment (%) were calculated based on the MP re- 
duction efficiencies of those selected treatment methods. 
From Fig. 4, the most economical advanced treatment options may 
be ozonation and activated carbon adsorption. They also can minimize 
the residues of MPs wastewater to the lowest level. The cost will fluctu- 
ate greatly depending on the scale of treatment, treatment targets and 
so on. It could be a large burden to the plants itself, in case of lacking 
funding from the government. 
 
3.6. Social aspects 
 
The last aspect to be consider is public acceptance of different treat- 
ment methods in MP control. So far, no paper has dealt with this issue, 
which is an interesting domain for future research. However, learning 
from the experience of Switzerland, people are willing to pay up to 
$37 ± 8 on the top of their water bill to reduce the risk of MPs (Logar 
et al., 2014). The higher perception they have towards environmental 
issues,  the  higher  value  they  agree  to  contribute  to  solve  the 
 
Table  9 
Comparison of calculated costs in Germany, Switzerland and the Netherlands for MP removal including post treatment in a sand filter. 
 
  Germany Switzerland Netherlands Sweden 
Small-scale WWTPs 
Medium-scale WWTPs 
€0.21 ± 0.08 
€0.19 ± 0.08 
€0.15–0.30 €0.22–€ 0.26 ± 0.05 
€0.18–€ 0.20 ± 0.05 
 
€0.15–0.30/m3 




Fig. 3. Comparison of annual costs per m3 of WWTP effluent in the Netherlands for three advanced MP treatment options: (1) Ozone + sand filtration, (2) PAC + sand filtration and (3) 
GAC filtration (data adapted from (Mulder et al., 2015)). Notes: • SF: sand filtration • VC: variable cost, CC: capital cost, MC: maintenance cost • S: small-scale (WWTPs serving 20,000 
people), M: medium-scale (100,000 people), L: large-scale (300,000 people) • GAC treatment option does not include sand filtration (VC-SF, CC-SF and MC-SF) • Value presented in 








environmental problems. Public media are a very useful domain to help 
to educate people about the risk of MP contamination on water re- 
sources and benefits from upgrading the WWTPs to reduce its risk, es- 




Based on the multicriteria analysis of MP treatment methods using 
full-scale and pilot-scale studies, several conclusions are summarised 
as follow: 
 
• MPs are posing a new threat to the water environment, which urges 
scientist community and legislative bodies to work together and es- 
tablish the regulations to control MPs. 
• Switzerland is the first country that tackles the MP discharge at the 
national level. Their policy was officially approved in regulation sys- 
tem and received positive supports from all relevant stakeholders. 
• Due to the diversity in nature of MPs, one single treatment technology 
is incapable to control all types of MPs. Each treatment method still 
has its drawbacks which need to be resolved. As a result, the combina- 
tion of different advanced methods is an interesting research topic. 
• From the specific case studies, ozonation and activated carbon adsorp- 
tion have a longer history as advanced technologies to upgrade tradi- 
tional WWTPs as they (i) have acceptable removal performance, (ii) 
are technically feasible, (iii) are sufficiently cost-effective. Neverthe- 
less, the other methods are also promising and worth to be studied 
thoroughly. 
  
After reviewing different methods for MP removal, some relevant 
topics are recommended for future research such as combination of var- 
ious advanced methods for MP removal, economic analysis of mem- 
brane and MBR processes for MP treatment and social acceptance of 
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